Emerging therapeutic strategies for head and neck tumors: from molecular targets to practical guidelines

Articles

ORIGINAL RESEARCH

Published on 21 Mar 2024

Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma

SYSTEMATIC REVIEW

Published on 17 Jan 2024

Durvalumab with or without tremelimumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis

ORIGINAL RESEARCH

Published on 30 Oct 2023

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for recurrent or metastatic nasopharyngeal cancer

REVIEW

Published on 25 Sep 2023

The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies

ORIGINAL RESEARCH

Published on 10 May 2023

Detection of herpes simplex virus in oral tongue squamous cell carcinoma

Share on

Frontiers in Pharmacology

Submit your idea

Articles

Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma

Durvalumab with or without tremelimumab for patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for recurrent or metastatic nasopharyngeal cancer

The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies

Detection of herpes simplex virus in oral tongue squamous cell carcinoma

Frontiers in Pharmacology